Position in COGT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$141,916,653
-$13,480,217 QoQ
Shares Held
3,667,097
-9.2% QoQ
Ownership
2.11%
of shares outstanding
% of Portfolio
7.84%
of 13F equity value
Holder Rank
#13
of 321 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kynam Capital Management, LP holds $1,765,169,848 across 29 Biotechnology names. COGT ranks #4 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CLDX |
Celldex Therapeutics, Inc.
|
5,322,908 | $198,065,406 | |
| 2 | SNDX |
Syndax Pharmaceuticals Inc
|
8,050,959 | $175,993,963 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
2,922,335 | $169,875,333 | |
| 4 | COGT |
Cogent Biosciences, Inc.
This page
|
3,667,097 | $141,916,653 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
2,890,059 | $124,012,431 | |
| 6 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,453,877 | $118,557,720 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,000,000 | $113,620,000 | |
| 8 | BEAM |
Beam Therapeutics Inc.
|
2,840,792 | $97,495,981 |
All Filings in COGT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $141,916,653 | 3,667,097 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $155,396,870 | 4,037,331 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $218,988,720 | 6,165,223 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $113,245,429 | 7,886,172 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $113,245,429 | 7,886,172 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $60,976,559 | 8,492,557 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $54,538,950 | 9,105,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $71,019,000 | 9,105,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $99,789,094 | 9,239,731 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $78,065,045 | 9,260,385 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $57,120,000 | 8,500,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $34,426,024 | 5,854,766 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,548,718 | 2,210,125 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,149,909 | 1,617,391 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,315,719 | 399,974 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,179,206 | 794,049 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,698,512 | 985,155 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,020,000 | 1,000,000 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $1,287,000 | 150,000 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||